1. Home
  2. GXAI vs CMND Comparison

GXAI vs CMND Comparison

Compare GXAI & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaxos.ai Inc.

GXAI

Gaxos.ai Inc.

HOLD

Current Price

$0.68

Market Cap

9.1M

Sector

N/A

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$0.97

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GXAI
CMND
Founded
2021
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
2.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
GXAI
CMND
Price
$0.68
$0.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9M
297.0K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
71.35
N/A
EPS
N/A
N/A
Revenue
$1,933,030.00
N/A
Revenue This Year
$271.23
N/A
Revenue Next Year
$36.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
47901.74
N/A
52 Week Low
$0.73
$0.07
52 Week High
$2.63
$4.66

Technical Indicators

Market Signals
Indicator
GXAI
CMND
Relative Strength Index (RSI) 40.55 26.47
Support Level N/A $0.59
Resistance Level $1.29 $1.27
Average True Range (ATR) 0.03 0.15
MACD -0.00 -0.09
Stochastic Oscillator 5.18 5.23

Price Performance

Historical Comparison
GXAI
CMND

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: